The safety and efficacy of recombinant human blood coagulation factor IX in previously untreated patients with severe or moderately severe hemophilia B [PDF]
, 2004 Amy D. Shapiro
openalex +1 more source
Sustained Clinical Benefit of AAV Gene Therapy in Severe Hemophilia B. [PDF]
N Engl J MedReiss UM +27 more
europepmc +1 more source
Comparative immunogenicity of recombinant B domain-deleted porcine factor VIII and Hyate:C in hemophilia A mice presensitized to human factor VIII [PDF]
, 2004 Ernest T. Parker +3 more
openalex +1 more source
Gene therapy as an innovative approach to the treatment of hemophilia B-a review. [PDF]
J Appl GenetWróblewska K +5 more
europepmc +1 more source
An Ex Vivo Keratinocyte Model for Gene Therapy of Hemophilia B
, 1997 Sean M. Page, George G. Brownlee
openalex +1 more source
161. Novel Pseudotyped AAV Vectors for Hemophilia B Gene Therapy [PDF]
, 2004 Lili Wang +3 more
openalex +1 more source
Hemophilia B With Intracranial Hemorrhage Rehabilitation in High-Dependency Unit: A Case Report. [PDF]
Clin Case RepFeng X, Zhu H, Han L, Xu H, He L.
europepmc +1 more source
Hepatitis B Vaccination in Children with Thalassemia, Hemophilia and Cancer
, 1996 Kaan Kavaklı +5 more
openalex +1 more source
163. Phenotypic Correction of a Hemophilia B Dog Following Systemic Administration of a Helper-Dependent Ad Vector Encoding Canine Coagulation Factor IX [PDF]
, 2004 Nicola Brunetti‐Pierri +4 more
openalex +1 more source